 David Orlicky
Concepts (903)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver | 46 | 2023 | 1816 | 2.330 |
Why?
| | Cholestasis | 12 | 2023 | 228 | 1.850 |
Why?
| | Pelvic Organ Prolapse | 3 | 2023 | 41 | 1.670 |
Why?
| | Non-alcoholic Fatty Liver Disease | 10 | 2022 | 280 | 1.590 |
Why?
| | Mice | 117 | 2023 | 15520 | 1.590 |
Why?
| | Ethanol | 19 | 2023 | 575 | 1.580 |
Why?
| | Lipid Metabolism | 18 | 2020 | 477 | 1.570 |
Why?
| | Hepatocytes | 9 | 2023 | 205 | 1.430 |
Why?
| | Animals | 165 | 2023 | 33381 | 1.380 |
Why?
| | Liver Diseases, Alcoholic | 10 | 2022 | 87 | 1.350 |
Why?
| | Perilipin-2 | 13 | 2019 | 36 | 1.330 |
Why?
| | Mice, Inbred C57BL | 54 | 2023 | 4908 | 1.150 |
Why?
| | Ligaments | 3 | 2023 | 47 | 1.120 |
Why?
| | Oxidative Stress | 23 | 2022 | 1178 | 1.060 |
Why?
| | Receptors, Prostaglandin | 13 | 1998 | 26 | 1.060 |
Why?
| | Fatty Liver | 12 | 2021 | 253 | 1.000 |
Why?
| | Obesity | 15 | 2023 | 2746 | 0.990 |
Why?
| | Dinoprost | 15 | 1996 | 31 | 0.970 |
Why?
| | Fatty Liver, Alcoholic | 5 | 2021 | 16 | 0.900 |
Why?
| | Uterus | 4 | 2020 | 194 | 0.870 |
Why?
| | Metabolic Syndrome | 7 | 2023 | 394 | 0.850 |
Why?
| | Bile Acids and Salts | 9 | 2023 | 179 | 0.820 |
Why?
| | Mice, Knockout | 34 | 2023 | 2680 | 0.820 |
Why?
| | Adipocytes | 6 | 2018 | 199 | 0.790 |
Why?
| | Aldehyde Dehydrogenase | 7 | 2017 | 134 | 0.760 |
Why?
| | Receptors, Estrogen | 2 | 2023 | 387 | 0.760 |
Why?
| | Fructokinases | 8 | 2023 | 63 | 0.750 |
Why?
| | Cytoplasm | 6 | 2016 | 269 | 0.740 |
Why?
| | Acetaminophen | 5 | 2022 | 244 | 0.740 |
Why?
| | Sacrum | 1 | 2020 | 67 | 0.730 |
Why?
| | Fructose | 9 | 2023 | 204 | 0.720 |
Why?
| | Aldehydes | 10 | 2022 | 154 | 0.720 |
Why?
| | Protein Carbonylation | 8 | 2018 | 52 | 0.720 |
Why?
| | Disease Models, Animal | 30 | 2023 | 3730 | 0.710 |
Why?
| | Milk | 7 | 2019 | 125 | 0.690 |
Why?
| | Liver Cirrhosis, Experimental | 1 | 2019 | 11 | 0.690 |
Why?
| | Chemical Warfare Agents | 6 | 2014 | 103 | 0.640 |
Why?
| | Dietary Fats | 5 | 2022 | 322 | 0.640 |
Why?
| | Skin | 9 | 2019 | 657 | 0.630 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 4 | 2021 | 195 | 0.630 |
Why?
| | Liver Diseases | 5 | 2023 | 282 | 0.620 |
Why?
| | Mechlorethamine | 5 | 2015 | 58 | 0.600 |
Why?
| | Kidney | 8 | 2019 | 1353 | 0.590 |
Why?
| | Antioxidants | 10 | 2023 | 564 | 0.590 |
Why?
| | Neoplasm Proteins | 9 | 2005 | 401 | 0.590 |
Why?
| | Lactation | 10 | 2019 | 160 | 0.580 |
Why?
| | Membrane Proteins | 12 | 2016 | 1055 | 0.570 |
Why?
| | Mammary Glands, Animal | 7 | 2019 | 124 | 0.560 |
Why?
| | Diet, High-Fat | 9 | 2020 | 247 | 0.550 |
Why?
| | Organelles | 2 | 2013 | 55 | 0.540 |
Why?
| | Parenteral Nutrition | 5 | 2023 | 92 | 0.540 |
Why?
| | Cholangitis, Sclerosing | 3 | 2023 | 75 | 0.540 |
Why?
| | Glutathione Transferase | 6 | 2019 | 97 | 0.530 |
Why?
| | Mitochondria | 6 | 2019 | 786 | 0.510 |
Why?
| | PTEN Phosphohydrolase | 4 | 2018 | 143 | 0.500 |
Why?
| | Ovary | 4 | 2022 | 205 | 0.490 |
Why?
| | Alcohol Drinking | 4 | 2016 | 652 | 0.460 |
Why?
| | DNA Damage | 7 | 2021 | 357 | 0.460 |
Why?
| | Inflammation | 16 | 2023 | 2566 | 0.450 |
Why?
| | Prostaglandins F | 6 | 1988 | 18 | 0.450 |
Why?
| | Male | 66 | 2023 | 57801 | 0.440 |
Why?
| | NF-kappa B | 5 | 2023 | 670 | 0.440 |
Why?
| | Peptides | 3 | 2008 | 879 | 0.420 |
Why?
| | Chemical and Drug Induced Liver Injury | 4 | 2022 | 136 | 0.420 |
Why?
| | Alcoholic Intoxication | 2 | 2023 | 63 | 0.420 |
Why?
| | Down Syndrome | 3 | 2023 | 356 | 0.420 |
Why?
| | Receptors, Virus | 2 | 2003 | 78 | 0.420 |
Why?
| | Superoxide Dismutase | 6 | 2019 | 339 | 0.410 |
Why?
| | Fructose Intolerance | 2 | 2023 | 6 | 0.400 |
Why?
| | Adenoviridae | 2 | 2003 | 191 | 0.400 |
Why?
| | Transfection | 8 | 2016 | 888 | 0.400 |
Why?
| | Mustard Gas | 5 | 2014 | 93 | 0.400 |
Why?
| | Thioredoxin Reductase 1 | 3 | 2023 | 8 | 0.390 |
Why?
| | Endometrium | 6 | 1988 | 61 | 0.370 |
Why?
| | Inflammatory Bowel Diseases | 3 | 2020 | 290 | 0.370 |
Why?
| | Energy Metabolism | 5 | 2019 | 767 | 0.370 |
Why?
| | Lens, Crystalline | 2 | 2022 | 126 | 0.370 |
Why?
| | Glutathione Reductase | 3 | 2019 | 22 | 0.360 |
Why?
| | Nitric Oxide Synthase Type I | 2 | 2020 | 26 | 0.360 |
Why?
| | Diabetes Mellitus, Experimental | 3 | 2017 | 211 | 0.360 |
Why?
| | Carcinoma, Hepatocellular | 2 | 2023 | 227 | 0.360 |
Why?
| | Carcinoma, Basal Cell | 2 | 2022 | 67 | 0.360 |
Why?
| | Burns | 2 | 2023 | 247 | 0.360 |
Why?
| | Precancerous Conditions | 2 | 2023 | 160 | 0.360 |
Why?
| | Thioredoxins | 3 | 2018 | 30 | 0.350 |
Why?
| | AMP-Activated Protein Kinases | 4 | 2014 | 178 | 0.350 |
Why?
| | Lipids | 7 | 2019 | 607 | 0.340 |
Why?
| | Fallopian Tubes | 2 | 2022 | 28 | 0.330 |
Why?
| | Sevelamer | 2 | 2020 | 9 | 0.330 |
Why?
| | Lung Injury | 2 | 2021 | 210 | 0.330 |
Why?
| | Colitis | 2 | 2021 | 219 | 0.330 |
Why?
| | Gene Expression Regulation, Enzymologic | 4 | 2021 | 290 | 0.330 |
Why?
| | Ultraviolet Rays | 4 | 2022 | 381 | 0.330 |
Why?
| | Female | 55 | 2023 | 61564 | 0.330 |
Why?
| | Taste | 2 | 2021 | 218 | 0.330 |
Why?
| | Immunity, Innate | 5 | 2023 | 745 | 0.330 |
Why?
| | Rats | 18 | 2022 | 5392 | 0.320 |
Why?
| | Gene Expression Regulation | 10 | 2021 | 2445 | 0.320 |
Why?
| | Skin Neoplasms | 3 | 2022 | 762 | 0.320 |
Why?
| | Humans | 63 | 2023 | 118972 | 0.310 |
Why?
| | Aldehyde Dehydrogenase, Mitochondrial | 5 | 2020 | 32 | 0.310 |
Why?
| | Hibernation | 2 | 2023 | 77 | 0.310 |
Why?
| | Leptin | 2 | 2020 | 231 | 0.310 |
Why?
| | Macrophages | 6 | 2021 | 1324 | 0.310 |
Why?
| | Liver Neoplasms | 2 | 2023 | 527 | 0.300 |
Why?
| | Lung | 7 | 2022 | 3664 | 0.300 |
Why?
| | Epithelial Cells | 7 | 2022 | 963 | 0.300 |
Why?
| | Genetic Vectors | 4 | 2010 | 302 | 0.290 |
Why?
| | Lipid Peroxidation | 5 | 2014 | 156 | 0.290 |
Why?
| | RNA, Messenger | 12 | 2023 | 2657 | 0.290 |
Why?
| | Triglycerides | 8 | 2021 | 519 | 0.280 |
Why?
| | Kidney Diseases | 2 | 2023 | 439 | 0.280 |
Why?
| | Lipid Droplets | 4 | 2019 | 21 | 0.280 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2019 | 420 | 0.280 |
Why?
| | Blister | 4 | 2014 | 39 | 0.280 |
Why?
| | Mice, Hairless | 9 | 2017 | 59 | 0.270 |
Why?
| | Irritants | 2 | 2017 | 41 | 0.270 |
Why?
| | HEK293 Cells | 5 | 2021 | 625 | 0.270 |
Why?
| | Diet, Western | 3 | 2022 | 69 | 0.270 |
Why?
| | Carcinoma, Pancreatic Ductal | 2 | 2020 | 210 | 0.270 |
Why?
| | Glycoproteins | 4 | 2021 | 319 | 0.270 |
Why?
| | Aldehyde Oxidoreductases | 3 | 2010 | 32 | 0.260 |
Why?
| | Pancreatic Neoplasms | 4 | 2020 | 734 | 0.260 |
Why?
| | Transduction, Genetic | 3 | 2003 | 116 | 0.260 |
Why?
| | Dioxanes | 2 | 2021 | 8 | 0.260 |
Why?
| | Endoplasmic Reticulum | 5 | 2019 | 241 | 0.260 |
Why?
| | Colon | 3 | 2023 | 238 | 0.260 |
Why?
| | Liver Cirrhosis | 5 | 2023 | 245 | 0.260 |
Why?
| | Signal Transduction | 13 | 2021 | 4709 | 0.260 |
Why?
| | Glycine | 2 | 2016 | 162 | 0.250 |
Why?
| | Immunohistochemistry | 12 | 2018 | 1691 | 0.250 |
Why?
| | Oxygen | 3 | 2018 | 854 | 0.250 |
Why?
| | Renal Insufficiency, Chronic | 2 | 2022 | 589 | 0.250 |
Why?
| | Silymarin | 2 | 2016 | 193 | 0.240 |
Why?
| | Cell Line | 14 | 2022 | 2707 | 0.240 |
Why?
| | Protein Processing, Post-Translational | 4 | 2017 | 408 | 0.240 |
Why?
| | Glycolipids | 2 | 2016 | 37 | 0.240 |
Why?
| | Gene Deletion | 4 | 2018 | 361 | 0.240 |
Why?
| | Dietary Sucrose | 2 | 2023 | 55 | 0.240 |
Why?
| | Lipoproteins | 2 | 2021 | 162 | 0.240 |
Why?
| | Tumor Necrosis Factor-alpha | 4 | 2023 | 1171 | 0.240 |
Why?
| | Glutathione | 7 | 2021 | 324 | 0.240 |
Why?
| | Digestive System Diseases | 1 | 2023 | 27 | 0.230 |
Why?
| | Azotemia | 1 | 2023 | 6 | 0.230 |
Why?
| | Proteomics | 5 | 2021 | 876 | 0.230 |
Why?
| | Mitochondrial Proteins | 2 | 2015 | 226 | 0.230 |
Why?
| | High Fructose Corn Syrup | 1 | 2023 | 10 | 0.230 |
Why?
| | Oxidative Phosphorylation | 3 | 2021 | 156 | 0.230 |
Why?
| | Patched-1 Receptor | 2 | 2022 | 15 | 0.230 |
Why?
| | Estrogen Receptor beta | 1 | 2023 | 37 | 0.230 |
Why?
| | Alprostadil | 4 | 1992 | 32 | 0.230 |
Why?
| | Carcinoma, Squamous Cell | 3 | 2018 | 610 | 0.230 |
Why?
| | Corpus Luteum | 4 | 1992 | 21 | 0.220 |
Why?
| | Torpor | 1 | 2023 | 15 | 0.220 |
Why?
| | Antidotes | 2 | 2015 | 126 | 0.220 |
Why?
| | Mast Cells | 4 | 2019 | 115 | 0.220 |
Why?
| | Catalase | 3 | 2017 | 123 | 0.220 |
Why?
| | Alcoholism | 2 | 2022 | 717 | 0.220 |
Why?
| | Membrane Glycoproteins | 4 | 2021 | 446 | 0.220 |
Why?
| | Cell Membrane | 5 | 2016 | 710 | 0.220 |
Why?
| | Phospholipids | 2 | 2017 | 208 | 0.220 |
Why?
| | Weight Gain | 4 | 2019 | 493 | 0.220 |
Why?
| | Dermatitis, Contact | 2 | 2013 | 20 | 0.220 |
Why?
| | Diabetic Nephropathies | 2 | 2017 | 289 | 0.220 |
Why?
| | Nucleotides | 2 | 2021 | 112 | 0.220 |
Why?
| | Herpesvirus 3, Human | 2 | 2021 | 389 | 0.220 |
Why?
| | Proteins | 6 | 2013 | 938 | 0.210 |
Why?
| | Cell Proliferation | 11 | 2020 | 2275 | 0.210 |
Why?
| | Endotoxemia | 1 | 2023 | 93 | 0.210 |
Why?
| | Estrogen Receptor alpha | 1 | 2023 | 126 | 0.210 |
Why?
| | Phosphorylation | 6 | 2020 | 1633 | 0.210 |
Why?
| | Receptors, Androgen | 1 | 2023 | 134 | 0.210 |
Why?
| | Autophagy | 3 | 2022 | 315 | 0.210 |
Why?
| | Abdominal Injuries | 1 | 2023 | 119 | 0.210 |
Why?
| | Thermogenesis | 2 | 2019 | 43 | 0.210 |
Why?
| | Hepatitis, Alcoholic | 1 | 2021 | 13 | 0.210 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2022 | 40 | 0.210 |
Why?
| | Phytosterols | 1 | 2021 | 9 | 0.200 |
Why?
| | Energy Intake | 3 | 2021 | 447 | 0.200 |
Why?
| | Colonic Neoplasms | 3 | 2011 | 224 | 0.200 |
Why?
| | Blotting, Western | 9 | 2015 | 1194 | 0.200 |
Why?
| | Isoxazoles | 1 | 2021 | 56 | 0.200 |
Why?
| | Bacterial Toxins | 1 | 2022 | 106 | 0.200 |
Why?
| | Cell Culture Techniques | 2 | 2018 | 356 | 0.200 |
Why?
| | Estrogens | 2 | 2023 | 328 | 0.200 |
Why?
| | Phenylurea Compounds | 1 | 2022 | 85 | 0.200 |
Why?
| | Drug Resistance | 1 | 2022 | 167 | 0.200 |
Why?
| | Glucose | 4 | 2023 | 953 | 0.200 |
Why?
| | Tandem Mass Spectrometry | 6 | 2022 | 421 | 0.200 |
Why?
| | Pneumococcal Infections | 1 | 2022 | 96 | 0.200 |
Why?
| | Adrenal Glands | 1 | 2021 | 72 | 0.200 |
Why?
| | Peroxiredoxins | 2 | 2018 | 23 | 0.200 |
Why?
| | Biomarkers | 7 | 2023 | 3588 | 0.200 |
Why?
| | Biomarkers, Tumor | 3 | 2016 | 1059 | 0.200 |
Why?
| | Eye | 1 | 2022 | 106 | 0.200 |
Why?
| | Adipose Tissue, Brown | 2 | 2019 | 71 | 0.200 |
Why?
| | NF-E2-Related Factor 2 | 2 | 2019 | 83 | 0.200 |
Why?
| | Janus Kinase 1 | 1 | 2020 | 22 | 0.190 |
Why?
| | Fatty Acids | 4 | 2022 | 407 | 0.190 |
Why?
| | 3T3 Cells | 4 | 2003 | 141 | 0.190 |
Why?
| | Receptors, Vasopressin | 1 | 2021 | 25 | 0.190 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2022 | 197 | 0.190 |
Why?
| | Quinolines | 1 | 2022 | 128 | 0.190 |
Why?
| | Hepatitis | 2 | 2019 | 46 | 0.190 |
Why?
| | Janus Kinase 2 | 1 | 2020 | 32 | 0.190 |
Why?
| | Azetidines | 1 | 2020 | 29 | 0.190 |
Why?
| | Mucoproteins | 1 | 2020 | 11 | 0.190 |
Why?
| | Apoptosis | 10 | 2020 | 2484 | 0.190 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 3 | 2016 | 57 | 0.190 |
Why?
| | Momordica charantia | 1 | 2020 | 14 | 0.190 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2020 | 31 | 0.190 |
Why?
| | Positive Regulatory Domain I-Binding Factor 1 | 1 | 2020 | 15 | 0.190 |
Why?
| | Vasopressins | 1 | 2021 | 64 | 0.190 |
Why?
| | Kidney Tubules | 2 | 2019 | 128 | 0.190 |
Why?
| | Microtubule-Associated Proteins | 4 | 2019 | 188 | 0.190 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2016 | 317 | 0.180 |
Why?
| | Carcinogens | 2 | 2013 | 108 | 0.180 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2022 | 200 | 0.180 |
Why?
| | Sugars | 1 | 2020 | 32 | 0.180 |
Why?
| | Lymphatic Vessels | 1 | 2020 | 54 | 0.180 |
Why?
| | Myometrium | 1 | 2020 | 35 | 0.180 |
Why?
| | Protein Biosynthesis | 3 | 2001 | 397 | 0.180 |
Why?
| | Monocytes | 2 | 2021 | 513 | 0.180 |
Why?
| | Lipoproteins, LDL | 1 | 2020 | 138 | 0.180 |
Why?
| | PPAR alpha | 3 | 2016 | 56 | 0.180 |
Why?
| | Herpesviridae Infections | 1 | 2021 | 142 | 0.180 |
Why?
| | Case-Control Studies | 4 | 2020 | 3171 | 0.180 |
Why?
| | Melanocytes | 1 | 2020 | 66 | 0.180 |
Why?
| | Gene Expression | 2 | 2023 | 1489 | 0.180 |
Why?
| | Cholesterol | 5 | 2022 | 373 | 0.180 |
Why?
| | SNARE Proteins | 1 | 2019 | 37 | 0.180 |
Why?
| | Deoxycytidine | 1 | 2020 | 136 | 0.180 |
Why?
| | Sucrose | 3 | 2018 | 104 | 0.180 |
Why?
| | Electron Microscope Tomography | 1 | 2019 | 35 | 0.180 |
Why?
| | Gastrointestinal Motility | 1 | 2019 | 26 | 0.180 |
Why?
| | Intestines | 3 | 2020 | 332 | 0.180 |
Why?
| | Cell Adhesion Molecules | 1 | 2020 | 180 | 0.180 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2020 | 1167 | 0.180 |
Why?
| | Adipose Tissue | 3 | 2019 | 606 | 0.180 |
Why?
| | Cytochrome P-450 CYP2E1 | 4 | 2021 | 38 | 0.180 |
Why?
| | Up-Regulation | 6 | 2022 | 872 | 0.170 |
Why?
| | Cholesterol, Dietary | 1 | 2019 | 16 | 0.170 |
Why?
| | Body Weight Maintenance | 1 | 2019 | 15 | 0.170 |
Why?
| | Cytokines | 5 | 2022 | 1900 | 0.170 |
Why?
| | Tumor Suppressor Protein p53 | 3 | 2020 | 455 | 0.170 |
Why?
| | Acylation | 1 | 2019 | 28 | 0.170 |
Why?
| | Ileum | 1 | 2019 | 100 | 0.170 |
Why?
| | Kupffer Cells | 1 | 2019 | 47 | 0.170 |
Why?
| | Leishmania major | 1 | 2018 | 6 | 0.170 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2020 | 814 | 0.170 |
Why?
| | Leishmaniasis, Cutaneous | 1 | 2018 | 7 | 0.170 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2022 | 527 | 0.170 |
Why?
| | Models, Animal | 2 | 2022 | 363 | 0.170 |
Why?
| | Bone Morphogenetic Protein 2 | 1 | 2019 | 90 | 0.170 |
Why?
| | Plant Extracts | 1 | 2020 | 165 | 0.170 |
Why?
| | Antineoplastic Agents, Phytogenic | 2 | 2019 | 180 | 0.160 |
Why?
| | Altitude Sickness | 1 | 2020 | 163 | 0.160 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2020 | 195 | 0.160 |
Why?
| | Emphysema | 1 | 2019 | 123 | 0.160 |
Why?
| | Thioredoxin-Disulfide Reductase | 1 | 2018 | 13 | 0.160 |
Why?
| | Thyroid Neoplasms | 1 | 2022 | 278 | 0.160 |
Why?
| | Cold Temperature | 1 | 2019 | 132 | 0.160 |
Why?
| | Adenocarcinoma | 3 | 2011 | 812 | 0.160 |
Why?
| | Carbohydrate Metabolism | 1 | 2018 | 50 | 0.160 |
Why?
| | Intestine, Small | 2 | 2020 | 131 | 0.160 |
Why?
| | Nanoparticles | 1 | 2022 | 325 | 0.160 |
Why?
| | Arteries | 1 | 2020 | 250 | 0.160 |
Why?
| | Uric Acid | 1 | 2021 | 354 | 0.160 |
Why?
| | Nitric Oxide | 3 | 2020 | 892 | 0.160 |
Why?
| | Adipose Tissue, White | 1 | 2018 | 35 | 0.160 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2022 | 2174 | 0.160 |
Why?
| | Protein Kinases | 1 | 2020 | 310 | 0.160 |
Why?
| | Phenotype | 3 | 2023 | 3003 | 0.160 |
Why?
| | Oxidation-Reduction | 5 | 2021 | 940 | 0.160 |
Why?
| | Bile Ducts | 1 | 2018 | 73 | 0.160 |
Why?
| | Gene Knockout Techniques | 1 | 2018 | 105 | 0.160 |
Why?
| | Hep G2 Cells | 4 | 2021 | 73 | 0.160 |
Why?
| | Desoxycorticosterone Acetate | 1 | 2017 | 3 | 0.160 |
Why?
| | Endothelial Cells | 1 | 2023 | 732 | 0.160 |
Why?
| | Relaxin | 1 | 2017 | 15 | 0.160 |
Why?
| | Glucosides | 1 | 2018 | 39 | 0.160 |
Why?
| | Pneumonia | 1 | 2023 | 592 | 0.160 |
Why?
| | Zebrafish Proteins | 1 | 2020 | 252 | 0.150 |
Why?
| | Sodium Chloride, Dietary | 1 | 2018 | 49 | 0.150 |
Why?
| | Intestinal Mucosa | 3 | 2016 | 531 | 0.150 |
Why?
| | Proteome | 2 | 2019 | 353 | 0.150 |
Why?
| | Acetyl-CoA Carboxylase | 2 | 2014 | 38 | 0.150 |
Why?
| | Base Sequence | 6 | 2015 | 2159 | 0.150 |
Why?
| | Benzhydryl Compounds | 1 | 2018 | 60 | 0.150 |
Why?
| | Insulin Resistance | 4 | 2019 | 1180 | 0.150 |
Why?
| | Phosphatidylethanolamine N-Methyltransferase | 1 | 2017 | 8 | 0.150 |
Why?
| | Virulence Factors | 1 | 2018 | 140 | 0.150 |
Why?
| | Sulfonamides | 1 | 2020 | 445 | 0.150 |
Why?
| | Phosgene | 1 | 2017 | 6 | 0.150 |
Why?
| | Cytochrome d Group | 1 | 2016 | 2 | 0.150 |
Why?
| | Oximes | 1 | 2017 | 18 | 0.150 |
Why?
| | Transcription, Genetic | 3 | 2005 | 1323 | 0.150 |
Why?
| | Cytochrome b Group | 1 | 2016 | 15 | 0.150 |
Why?
| | Glutamate-Cysteine Ligase | 2 | 2022 | 18 | 0.150 |
Why?
| | Reactive Oxygen Species | 3 | 2022 | 576 | 0.150 |
Why?
| | Mitochondria, Muscle | 1 | 2018 | 97 | 0.150 |
Why?
| | Hypersensitivity | 1 | 2020 | 268 | 0.150 |
Why?
| | Vasodilation | 1 | 2020 | 457 | 0.150 |
Why?
| | Metabolic Diseases | 1 | 2018 | 103 | 0.150 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2019 | 245 | 0.150 |
Why?
| | Nephrosclerosis | 1 | 2016 | 6 | 0.150 |
Why?
| | Temperature | 2 | 2018 | 622 | 0.150 |
Why?
| | Apocrine Glands | 1 | 2016 | 4 | 0.150 |
Why?
| | Sciuridae | 2 | 2023 | 145 | 0.150 |
Why?
| | Disease Progression | 6 | 2020 | 2490 | 0.150 |
Why?
| | DNA Primers | 5 | 2015 | 533 | 0.150 |
Why?
| | Spleen | 2 | 2018 | 510 | 0.150 |
Why?
| | Cell Differentiation | 7 | 2020 | 1753 | 0.140 |
Why?
| | Xanthine Dehydrogenase | 1 | 2016 | 34 | 0.140 |
Why?
| | Amino Acid Sequence | 6 | 2020 | 2071 | 0.140 |
Why?
| | Chemical and Drug Induced Liver Injury, Chronic | 1 | 2016 | 9 | 0.140 |
Why?
| | Necrosis | 2 | 2015 | 230 | 0.140 |
Why?
| | Zebrafish | 1 | 2020 | 434 | 0.140 |
Why?
| | Metalloporphyrins | 2 | 2014 | 103 | 0.140 |
Why?
| | End Stage Liver Disease | 1 | 2017 | 73 | 0.140 |
Why?
| | Mice, Obese | 3 | 2023 | 58 | 0.140 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2016 | 48 | 0.140 |
Why?
| | Heart Defects, Congenital | 1 | 2023 | 703 | 0.140 |
Why?
| | Homocystinuria | 1 | 2017 | 63 | 0.140 |
Why?
| | Choline | 1 | 2017 | 109 | 0.140 |
Why?
| | Salmonella enterica | 1 | 2016 | 53 | 0.140 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2018 | 157 | 0.140 |
Why?
| | Cells, Cultured | 10 | 2020 | 4077 | 0.140 |
Why?
| | Rabbits | 10 | 2002 | 780 | 0.140 |
Why?
| | Acute Kidney Injury | 1 | 2023 | 709 | 0.140 |
Why?
| | Optical Imaging | 1 | 2016 | 56 | 0.140 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 1996 | 74 | 0.140 |
Why?
| | Estradiol | 4 | 1988 | 476 | 0.140 |
Why?
| | Disease Susceptibility | 2 | 2020 | 331 | 0.140 |
Why?
| | Liver Cirrhosis, Alcoholic | 1 | 2015 | 19 | 0.140 |
Why?
| | Microbiota | 1 | 2023 | 656 | 0.140 |
Why?
| | Epithelium, Corneal | 1 | 2016 | 40 | 0.140 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2020 | 671 | 0.140 |
Why?
| | Acetylcysteine | 2 | 2022 | 148 | 0.140 |
Why?
| | Fibrosis | 4 | 2022 | 483 | 0.140 |
Why?
| | Severity of Illness Index | 2 | 2020 | 2674 | 0.130 |
Why?
| | Protein Structure, Tertiary | 3 | 2011 | 823 | 0.130 |
Why?
| | Recombinant Proteins | 3 | 2017 | 1308 | 0.130 |
Why?
| | Biliary Atresia | 1 | 2018 | 224 | 0.130 |
Why?
| | Lung Neoplasms | 3 | 2018 | 2220 | 0.130 |
Why?
| | Peroxidase | 5 | 2015 | 170 | 0.130 |
Why?
| | Lysine | 1 | 2017 | 248 | 0.130 |
Why?
| | Epidermis | 2 | 2014 | 152 | 0.130 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2016 | 125 | 0.130 |
Why?
| | Cell Division | 7 | 1988 | 776 | 0.130 |
Why?
| | Pelvis | 1 | 2016 | 92 | 0.130 |
Why?
| | Skin Diseases | 1 | 2017 | 125 | 0.130 |
Why?
| | Down-Regulation | 4 | 2022 | 627 | 0.130 |
Why?
| | Mice, Transgenic | 5 | 2021 | 2025 | 0.130 |
Why?
| | Fetal Growth Retardation | 1 | 2020 | 468 | 0.130 |
Why?
| | Hematopoietic System | 1 | 2014 | 7 | 0.130 |
Why?
| | Chemokines | 3 | 2023 | 230 | 0.130 |
Why?
| | MicroRNAs | 1 | 2021 | 637 | 0.130 |
Why?
| | Carcinogenesis | 3 | 2023 | 182 | 0.130 |
Why?
| | Space Flight | 1 | 2016 | 129 | 0.130 |
Why?
| | Molecular Sequence Data | 6 | 2015 | 2871 | 0.130 |
Why?
| | Cytoprotection | 2 | 2015 | 55 | 0.130 |
Why?
| | Diet | 3 | 2018 | 1153 | 0.130 |
Why?
| | Protein Kinase Inhibitors | 1 | 2020 | 811 | 0.130 |
Why?
| | Interleukin-6 | 3 | 2023 | 688 | 0.130 |
Why?
| | Breast Feeding | 1 | 2018 | 386 | 0.130 |
Why?
| | Microscopy, Fluorescence | 1 | 2016 | 412 | 0.130 |
Why?
| | Alanine Transaminase | 4 | 2016 | 152 | 0.120 |
Why?
| | Vagina | 1 | 2016 | 148 | 0.120 |
Why?
| | Mice, Inbred ICR | 3 | 2021 | 111 | 0.120 |
Why?
| | Weight Loss | 1 | 2019 | 655 | 0.120 |
Why?
| | Motor Activity | 1 | 2019 | 660 | 0.120 |
Why?
| | Body Weight | 5 | 2016 | 934 | 0.120 |
Why?
| | 4-Nitroquinoline-1-oxide | 1 | 2013 | 5 | 0.120 |
Why?
| | Hyperkeratosis, Epidermolytic | 1 | 2014 | 19 | 0.120 |
Why?
| | Dermis | 1 | 2014 | 29 | 0.120 |
Why?
| | Metabolism, Inborn Errors | 1 | 2014 | 38 | 0.120 |
Why?
| | Cloning, Molecular | 4 | 2010 | 546 | 0.120 |
Why?
| | Tongue Neoplasms | 1 | 2013 | 21 | 0.120 |
Why?
| | Stilbenes | 1 | 2013 | 35 | 0.120 |
Why?
| | Colorectal Neoplasms | 1 | 2020 | 628 | 0.120 |
Why?
| | Methylation | 1 | 2014 | 204 | 0.120 |
Why?
| | Prediabetic State | 1 | 2016 | 234 | 0.120 |
Why?
| | Melanoma | 1 | 2020 | 664 | 0.120 |
Why?
| | Macrophage Activation | 3 | 2023 | 168 | 0.120 |
Why?
| | Middle Aged | 9 | 2020 | 27617 | 0.120 |
Why?
| | Heart | 1 | 2017 | 631 | 0.120 |
Why?
| | Grape Seed Extract | 1 | 2013 | 41 | 0.120 |
Why?
| | Kidney Tubules, Proximal | 1 | 2014 | 131 | 0.110 |
Why?
| | Phosphoproteins | 2 | 2013 | 308 | 0.110 |
Why?
| | Tetradecanoylphorbol Acetate | 2 | 1996 | 155 | 0.110 |
Why?
| | Metabolomics | 4 | 2022 | 550 | 0.110 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2016 | 139 | 0.110 |
Why?
| | Anticarcinogenic Agents | 1 | 2013 | 68 | 0.110 |
Why?
| | B-Lymphocytes | 1 | 2018 | 770 | 0.110 |
Why?
| | Chromatography, Liquid | 4 | 2017 | 355 | 0.110 |
Why?
| | Isoproterenol | 1 | 2013 | 125 | 0.110 |
Why?
| | Organ Size | 4 | 2016 | 460 | 0.110 |
Why?
| | Protein Structure, Secondary | 3 | 2018 | 338 | 0.110 |
Why?
| | Lymphopenia | 1 | 2013 | 48 | 0.110 |
Why?
| | Inositol Phosphates | 3 | 1988 | 23 | 0.110 |
Why?
| | Anti-Inflammatory Agents | 1 | 2016 | 465 | 0.110 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2013 | 62 | 0.110 |
Why?
| | Gastrointestinal Microbiome | 2 | 2020 | 548 | 0.110 |
Why?
| | Coxsackie and Adenovirus Receptor-Like Membrane Protein | 2 | 2003 | 7 | 0.110 |
Why?
| | Green Fluorescent Proteins | 3 | 2011 | 395 | 0.110 |
Why?
| | Microfilament Proteins | 1 | 2013 | 134 | 0.110 |
Why?
| | Natural Killer T-Cells | 1 | 2013 | 62 | 0.110 |
Why?
| | Mothers | 2 | 2018 | 682 | 0.110 |
Why?
| | Testis | 1 | 1992 | 144 | 0.110 |
Why?
| | Myocardium | 1 | 2017 | 970 | 0.100 |
Why?
| | Perilipin-3 | 2 | 2008 | 2 | 0.100 |
Why?
| | Carrier Proteins | 3 | 2017 | 726 | 0.100 |
Why?
| | Cattle | 6 | 2016 | 978 | 0.100 |
Why?
| | Fructose-Bisphosphate Aldolase | 2 | 2023 | 9 | 0.100 |
Why?
| | Arousal | 1 | 2012 | 157 | 0.100 |
Why?
| | DNA, Complementary | 3 | 2016 | 268 | 0.100 |
Why?
| | Reactive Nitrogen Species | 1 | 2011 | 25 | 0.100 |
Why?
| | Mammals | 2 | 2023 | 253 | 0.100 |
Why?
| | Eye Proteins | 2 | 2021 | 77 | 0.100 |
Why?
| | Taurine | 1 | 2011 | 46 | 0.100 |
Why?
| | Administration, Cutaneous | 3 | 2017 | 119 | 0.100 |
Why?
| | Neurons | 1 | 2019 | 1345 | 0.100 |
Why?
| | Nasal Cavity | 1 | 2011 | 47 | 0.100 |
Why?
| | Ligands | 2 | 2023 | 567 | 0.100 |
Why?
| | Olfactory Mucosa | 1 | 2011 | 59 | 0.100 |
Why?
| | Microtubules | 1 | 2013 | 241 | 0.100 |
Why?
| | Mutation | 3 | 2020 | 3457 | 0.100 |
Why?
| | Acetaldehyde | 1 | 2010 | 20 | 0.090 |
Why?
| | Cohort Studies | 1 | 2020 | 5116 | 0.090 |
Why?
| | Chenodeoxycholic Acid | 2 | 2021 | 12 | 0.090 |
Why?
| | Heme Oxygenase-1 | 2 | 2021 | 53 | 0.090 |
Why?
| | Blood Proteins | 1 | 2012 | 248 | 0.090 |
Why?
| | Luminescent Proteins | 2 | 2001 | 174 | 0.090 |
Why?
| | Glycolysis | 2 | 2021 | 224 | 0.090 |
Why?
| | Multidrug Resistance-Associated Proteins | 2 | 2021 | 36 | 0.090 |
Why?
| | Mice, Inbred BALB C | 3 | 2018 | 1206 | 0.090 |
Why?
| | Casein Kinase II | 1 | 2009 | 21 | 0.090 |
Why?
| | COS Cells | 2 | 2003 | 184 | 0.090 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 982 | 0.090 |
Why?
| | Pregnancy | 6 | 2020 | 5690 | 0.090 |
Why?
| | Peroxiredoxin VI | 1 | 2009 | 5 | 0.090 |
Why?
| | Protein Folding | 1 | 2011 | 250 | 0.090 |
Why?
| | Immediate-Early Proteins | 1 | 2009 | 55 | 0.090 |
Why?
| | Hyaluronan Receptors | 1 | 2009 | 93 | 0.090 |
Why?
| | Recombinant Fusion Proteins | 2 | 2011 | 653 | 0.090 |
Why?
| | Viral Envelope Proteins | 1 | 2009 | 80 | 0.090 |
Why?
| | Serine | 1 | 2009 | 138 | 0.080 |
Why?
| | Biomarkers, Pharmacological | 1 | 2008 | 26 | 0.080 |
Why?
| | Prospective Studies | 1 | 2020 | 6471 | 0.080 |
Why?
| | Lysosomes | 2 | 2019 | 136 | 0.080 |
Why?
| | Cysteine Proteinase Inhibitors | 2 | 2014 | 50 | 0.080 |
Why?
| | Rats, Sprague-Dawley | 4 | 2016 | 2478 | 0.080 |
Why?
| | Organ Specificity | 3 | 2018 | 278 | 0.080 |
Why?
| | Oleic Acid | 1 | 2008 | 34 | 0.080 |
Why?
| | Exosomes | 1 | 2009 | 92 | 0.080 |
Why?
| | Hypertension | 1 | 2017 | 1203 | 0.080 |
Why?
| | Mutant Proteins | 1 | 2008 | 100 | 0.080 |
Why?
| | Endoplasmic Reticulum Stress | 2 | 2019 | 97 | 0.080 |
Why?
| | Structure-Activity Relationship | 2 | 2008 | 522 | 0.080 |
Why?
| | Kidney Function Tests | 2 | 2019 | 164 | 0.080 |
Why?
| | Tissue Distribution | 3 | 2007 | 334 | 0.080 |
Why?
| | Tumor Suppressor Proteins | 2 | 2020 | 289 | 0.080 |
Why?
| | Adiposity | 2 | 2015 | 516 | 0.080 |
Why?
| | Muscle, Smooth | 2 | 2019 | 157 | 0.080 |
Why?
| | Vasotocin | 1 | 2006 | 5 | 0.070 |
Why?
| | Affinity Labels | 3 | 1992 | 26 | 0.070 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2007 | 35 | 0.070 |
Why?
| | Adult | 9 | 2020 | 31512 | 0.070 |
Why?
| | Urethane | 1 | 2007 | 41 | 0.070 |
Why?
| | Muscle Tonus | 1 | 2006 | 19 | 0.070 |
Why?
| | Uterine Contraction | 1 | 2006 | 16 | 0.070 |
Why?
| | Risk Factors | 1 | 2020 | 9000 | 0.070 |
Why?
| | Lipogenesis | 2 | 2018 | 66 | 0.070 |
Why?
| | Neoplasm Invasiveness | 2 | 2020 | 462 | 0.070 |
Why?
| | Tumor Cells, Cultured | 3 | 2020 | 874 | 0.070 |
Why?
| | Prostaglandins | 1 | 2006 | 78 | 0.070 |
Why?
| | Sugar Phosphates | 1 | 1986 | 2 | 0.070 |
Why?
| | Lizards | 1 | 2006 | 35 | 0.070 |
Why?
| | Azides | 3 | 1992 | 47 | 0.070 |
Why?
| | Mice, Nude | 2 | 2020 | 663 | 0.070 |
Why?
| | Nitric Oxide Synthase Type II | 3 | 2014 | 165 | 0.070 |
Why?
| | Thermodynamics | 1 | 2008 | 392 | 0.070 |
Why?
| | Amidinotransferases | 2 | 2016 | 2 | 0.070 |
Why?
| | Guanidinoacetate N-Methyltransferase | 2 | 2016 | 5 | 0.070 |
Why?
| | Acetylation | 2 | 2017 | 217 | 0.070 |
Why?
| | S-Adenosylhomocysteine | 2 | 2016 | 21 | 0.070 |
Why?
| | S-Adenosylmethionine | 2 | 2016 | 49 | 0.070 |
Why?
| | CCAAT-Enhancer-Binding Protein-alpha | 1 | 2005 | 16 | 0.070 |
Why?
| | Kidney Glomerulus | 2 | 2018 | 133 | 0.070 |
Why?
| | DNA Replication | 1 | 1987 | 211 | 0.070 |
Why?
| | Ovarian Neoplasms | 1 | 2010 | 420 | 0.070 |
Why?
| | Bone Marrow | 1 | 2007 | 255 | 0.070 |
Why?
| | Feces | 2 | 2020 | 396 | 0.070 |
Why?
| | Metabolic Networks and Pathways | 2 | 2019 | 176 | 0.070 |
Why?
| | Sequence Analysis, RNA | 2 | 2018 | 409 | 0.070 |
Why?
| | Perilipin-1 | 2 | 2019 | 16 | 0.060 |
Why?
| | Adenoma | 1 | 2007 | 191 | 0.060 |
Why?
| | Chronic Disease | 1 | 2011 | 1636 | 0.060 |
Why?
| | Homocysteine | 2 | 2016 | 137 | 0.060 |
Why?
| | Aged | 6 | 2023 | 19657 | 0.060 |
Why?
| | Diabetes Mellitus | 2 | 2018 | 942 | 0.060 |
Why?
| | Transforming Growth Factor beta | 2 | 2020 | 462 | 0.060 |
Why?
| | Oxygen Consumption | 2 | 2018 | 586 | 0.060 |
Why?
| | Edema | 2 | 2017 | 124 | 0.060 |
Why?
| | Transcription Factors | 3 | 2019 | 1570 | 0.060 |
Why?
| | Rats, Wistar | 2 | 2016 | 399 | 0.060 |
Why?
| | Tamoxifen | 2 | 2020 | 198 | 0.060 |
Why?
| | Diet, Fat-Restricted | 2 | 2015 | 76 | 0.060 |
Why?
| | Polymerase Chain Reaction | 2 | 1998 | 1012 | 0.060 |
Why?
| | Cyclic GMP | 2 | 2019 | 109 | 0.060 |
Why?
| | Poly Adenosine Diphosphate Ribose | 1 | 2023 | 2 | 0.060 |
Why?
| | Cyclooxygenase 2 | 2 | 2015 | 168 | 0.060 |
Why?
| | Glycoside Hydrolases | 1 | 2023 | 30 | 0.060 |
Why?
| | Mammary Glands, Human | 2 | 2016 | 61 | 0.060 |
Why?
| | Genes, Regulator | 1 | 2023 | 33 | 0.060 |
Why?
| | Gene Expression Profiling | 3 | 2017 | 1597 | 0.060 |
Why?
| | Acute-Phase Reaction | 1 | 2023 | 39 | 0.060 |
Why?
| | Macrophages, Alveolar | 1 | 2007 | 359 | 0.060 |
Why?
| | ARNTL Transcription Factors | 1 | 2023 | 16 | 0.060 |
Why?
| | Furosemide | 1 | 2023 | 35 | 0.060 |
Why?
| | Time Factors | 5 | 2015 | 6412 | 0.060 |
Why?
| | Lipocalin-2 | 1 | 2023 | 64 | 0.060 |
Why?
| | NF-kappa B p50 Subunit | 1 | 2023 | 26 | 0.060 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2005 | 369 | 0.060 |
Why?
| | Receptors, Interferon | 1 | 2023 | 49 | 0.060 |
Why?
| | Cell Survival | 4 | 2014 | 1047 | 0.050 |
Why?
| | Sequence Deletion | 1 | 2003 | 171 | 0.050 |
Why?
| | Antigens, CD | 2 | 2005 | 460 | 0.050 |
Why?
| | Chemokine CCL7 | 1 | 2022 | 3 | 0.050 |
Why?
| | Buthionine Sulfoximine | 1 | 2022 | 7 | 0.050 |
Why?
| | Interferons | 1 | 2023 | 151 | 0.050 |
Why?
| | 8-Bromo Cyclic Adenosine Monophosphate | 2 | 1996 | 17 | 0.050 |
Why?
| | Fluorine | 2 | 1992 | 15 | 0.050 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2003 | 178 | 0.050 |
Why?
| | Cervix Uteri | 1 | 2002 | 48 | 0.050 |
Why?
| | Adenovirus E1A Proteins | 1 | 2001 | 11 | 0.050 |
Why?
| | Rats, Inbred F344 | 2 | 1992 | 245 | 0.050 |
Why?
| | Benzimidazoles | 1 | 2023 | 140 | 0.050 |
Why?
| | Sterols | 1 | 2021 | 17 | 0.050 |
Why?
| | Nuclear Receptor Co-Repressor 1 | 1 | 2021 | 16 | 0.050 |
Why?
| | Adenoviruses, Human | 1 | 2001 | 24 | 0.050 |
Why?
| | Immune Sera | 2 | 1992 | 82 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2007 | 372 | 0.050 |
Why?
| | Dysbiosis | 1 | 2023 | 147 | 0.050 |
Why?
| | Heme | 1 | 2021 | 54 | 0.050 |
Why?
| | Systems Analysis | 1 | 2021 | 23 | 0.050 |
Why?
| | Sodium Glutamate | 1 | 2021 | 11 | 0.050 |
Why?
| | Homeostasis | 2 | 2016 | 594 | 0.050 |
Why?
| | Intestinal Diseases | 1 | 2021 | 30 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2015 | 1945 | 0.050 |
Why?
| | PAX6 Transcription Factor | 1 | 2021 | 23 | 0.050 |
Why?
| | I-kappa B Proteins | 1 | 2022 | 80 | 0.050 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 150 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2021 | 79 | 0.050 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2002 | 103 | 0.050 |
Why?
| | Dilatation | 1 | 2022 | 56 | 0.050 |
Why?
| | Bilirubin | 1 | 2021 | 95 | 0.050 |
Why?
| | Silicon Dioxide | 1 | 2022 | 95 | 0.050 |
Why?
| | Macaca fascicularis | 1 | 2021 | 53 | 0.050 |
Why?
| | Infliximab | 1 | 2021 | 94 | 0.050 |
Why?
| | Cation Exchange Resins | 1 | 2001 | 7 | 0.050 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2021 | 135 | 0.050 |
Why?
| | Polylysine | 1 | 2001 | 19 | 0.050 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2001 | 84 | 0.050 |
Why?
| | Histological Techniques | 1 | 2021 | 43 | 0.050 |
Why?
| | B7-H1 Antigen | 1 | 2022 | 144 | 0.050 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2021 | 136 | 0.050 |
Why?
| | Promoter Regions, Genetic | 2 | 2005 | 1158 | 0.050 |
Why?
| | C-Reactive Protein | 1 | 2023 | 360 | 0.050 |
Why?
| | Drinking | 1 | 2021 | 36 | 0.050 |
Why?
| | Hedgehog Proteins | 1 | 2022 | 175 | 0.050 |
Why?
| | Indicators and Reagents | 1 | 2001 | 100 | 0.050 |
Why?
| | Plant Oils | 1 | 2000 | 28 | 0.050 |
Why?
| | Intestine, Large | 1 | 2020 | 15 | 0.050 |
Why?
| | Ursodeoxycholic Acid | 1 | 2020 | 22 | 0.050 |
Why?
| | Intercellular Junctions | 1 | 2020 | 34 | 0.050 |
Why?
| | Streptococcus pneumoniae | 1 | 2022 | 141 | 0.050 |
Why?
| | DNA-Binding Proteins | 2 | 2019 | 1346 | 0.050 |
Why?
| | Proteostasis | 1 | 2020 | 20 | 0.050 |
Why?
| | Receptors, Purinergic P2X2 | 1 | 2020 | 16 | 0.050 |
Why?
| | Pyrones | 1 | 2020 | 9 | 0.050 |
Why?
| | Receptors, Purinergic P2X3 | 1 | 2020 | 16 | 0.050 |
Why?
| | Genes, Transgenic, Suicide | 1 | 2020 | 8 | 0.050 |
Why?
| | Dextran Sulfate | 1 | 2020 | 71 | 0.050 |
Why?
| | Morphogenesis | 1 | 2021 | 167 | 0.050 |
Why?
| | Fluorescence | 1 | 2001 | 159 | 0.050 |
Why?
| | Calcium | 1 | 2006 | 1169 | 0.050 |
Why?
| | Leukocytes | 1 | 2022 | 290 | 0.050 |
Why?
| | Forkhead Transcription Factors | 1 | 2021 | 182 | 0.050 |
Why?
| | Gene Knockdown Techniques | 1 | 2021 | 311 | 0.050 |
Why?
| | Lactobacillus | 1 | 2020 | 23 | 0.050 |
Why?
| | Permeability | 1 | 2020 | 156 | 0.050 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2022 | 176 | 0.050 |
Why?
| | Cecum | 1 | 2020 | 37 | 0.050 |
Why?
| | Cell Line, Tumor | 3 | 2016 | 2851 | 0.050 |
Why?
| | Biphenyl Compounds | 1 | 2020 | 52 | 0.050 |
Why?
| | Cytomegalovirus | 1 | 2001 | 144 | 0.050 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2020 | 83 | 0.050 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2019 | 24 | 0.050 |
Why?
| | Feeding Behavior | 2 | 2018 | 601 | 0.050 |
Why?
| | R-SNARE Proteins | 1 | 2019 | 19 | 0.050 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 167 | 0.050 |
Why?
| | Ki-67 Antigen | 2 | 2016 | 108 | 0.050 |
Why?
| | Glomerular Filtration Rate | 1 | 2023 | 683 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 126 | 0.040 |
Why?
| | Thiophenes | 1 | 2020 | 106 | 0.040 |
Why?
| | Purines | 1 | 2020 | 161 | 0.040 |
Why?
| | Binding Sites | 1 | 2003 | 1224 | 0.040 |
Why?
| | Pituitary Gland | 1 | 2020 | 163 | 0.040 |
Why?
| | Uncoupling Protein 1 | 1 | 2019 | 16 | 0.040 |
Why?
| | Collagen Type I | 1 | 2020 | 114 | 0.040 |
Why?
| | Iodide Peroxidase | 1 | 2019 | 25 | 0.040 |
Why?
| | Interferon-alpha | 1 | 2020 | 191 | 0.040 |
Why?
| | Interleukin-1beta | 1 | 2021 | 379 | 0.040 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2002 | 216 | 0.040 |
Why?
| | Alanine | 1 | 2019 | 102 | 0.040 |
Why?
| | Polymers | 2 | 2014 | 482 | 0.040 |
Why?
| | Food Preferences | 1 | 2020 | 119 | 0.040 |
Why?
| | Cyclin D1 | 1 | 2019 | 61 | 0.040 |
Why?
| | Leishmania donovani | 1 | 2018 | 3 | 0.040 |
Why?
| | Protein Binding | 3 | 2011 | 1975 | 0.040 |
Why?
| | Parasite Load | 1 | 2018 | 8 | 0.040 |
Why?
| | Photoperiod | 1 | 2019 | 55 | 0.040 |
Why?
| | Sirtuins | 1 | 2019 | 34 | 0.040 |
Why?
| | Drug Therapy, Combination | 1 | 2022 | 965 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 187 | 0.040 |
Why?
| | gamma Catenin | 1 | 2018 | 17 | 0.040 |
Why?
| | Desmoglein 3 | 1 | 2018 | 17 | 0.040 |
Why?
| | Chemoprevention | 1 | 2019 | 89 | 0.040 |
Why?
| | beta Catenin | 1 | 2020 | 219 | 0.040 |
Why?
| | Metaplasia | 1 | 2018 | 57 | 0.040 |
Why?
| | Peptide Fragments | 1 | 2003 | 702 | 0.040 |
Why?
| | Breast Neoplasms | 1 | 2010 | 1965 | 0.040 |
Why?
| | Ribosomes | 1 | 2019 | 142 | 0.040 |
Why?
| | Bronchial Diseases | 1 | 2018 | 34 | 0.040 |
Why?
| | Mice, 129 Strain | 1 | 2018 | 75 | 0.040 |
Why?
| | Cell Respiration | 1 | 2018 | 76 | 0.040 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2019 | 190 | 0.040 |
Why?
| | Cell Cycle Checkpoints | 1 | 2018 | 87 | 0.040 |
Why?
| | Inhibitor of Apoptosis Proteins | 3 | 2003 | 44 | 0.040 |
Why?
| | Sirtuin 3 | 1 | 2019 | 60 | 0.040 |
Why?
| | Protein Transport | 1 | 2019 | 412 | 0.040 |
Why?
| | Cholic Acids | 1 | 2017 | 17 | 0.040 |
Why?
| | Glomerular Mesangium | 1 | 2017 | 19 | 0.040 |
Why?
| | Sarcopenia | 1 | 2019 | 72 | 0.040 |
Why?
| | Oligonucleotides, Antisense | 1 | 1998 | 100 | 0.040 |
Why?
| | Adiponectin | 2 | 2013 | 226 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2020 | 740 | 0.040 |
Why?
| | Azo Compounds | 1 | 2017 | 25 | 0.040 |
Why?
| | Virulence | 1 | 2018 | 240 | 0.040 |
Why?
| | Adenine | 1 | 2019 | 223 | 0.040 |
Why?
| | Mice, Inbred DBA | 1 | 2017 | 174 | 0.040 |
Why?
| | Pyrazoles | 1 | 2020 | 363 | 0.040 |
Why?
| | Heart Function Tests | 1 | 2017 | 61 | 0.040 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type I | 1 | 2017 | 2 | 0.040 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2017 | 22 | 0.040 |
Why?
| | Urinalysis | 1 | 2017 | 68 | 0.040 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2017 | 74 | 0.040 |
Why?
| | Isoenzymes | 1 | 2018 | 297 | 0.040 |
Why?
| | Islets of Langerhans | 1 | 2003 | 739 | 0.040 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2016 | 18 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2019 | 439 | 0.040 |
Why?
| | Immunoenzyme Techniques | 2 | 2011 | 195 | 0.040 |
Why?
| | Podocytes | 1 | 2017 | 57 | 0.040 |
Why?
| | Erythema | 1 | 2017 | 24 | 0.040 |
Why?
| | Models, Molecular | 2 | 2013 | 1435 | 0.040 |
Why?
| | Adaptive Immunity | 1 | 2018 | 161 | 0.040 |
Why?
| | Staining and Labeling | 2 | 1992 | 146 | 0.040 |
Why?
| | Indomethacin | 2 | 2006 | 75 | 0.040 |
Why?
| | Bacteria | 1 | 2023 | 757 | 0.040 |
Why?
| | Bronchi | 1 | 2018 | 242 | 0.040 |
Why?
| | Butyrophilins | 1 | 2016 | 5 | 0.040 |
Why?
| | Homeodomain Proteins | 1 | 2020 | 468 | 0.040 |
Why?
| | Blood Glucose | 2 | 2018 | 1939 | 0.040 |
Why?
| | DNA | 5 | 1986 | 1388 | 0.040 |
Why?
| | Fibroblast Growth Factors | 1 | 2018 | 175 | 0.040 |
Why?
| | Albuminuria | 1 | 2017 | 195 | 0.040 |
Why?
| | Intracellular Membranes | 1 | 2016 | 74 | 0.040 |
Why?
| | Chromosomes, Artificial, Yeast | 1 | 1996 | 4 | 0.040 |
Why?
| | Okadaic Acid | 1 | 1996 | 12 | 0.040 |
Why?
| | Hybrid Cells | 1 | 1996 | 46 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2019 | 502 | 0.040 |
Why?
| | RNA-Binding Proteins | 1 | 2019 | 371 | 0.040 |
Why?
| | Hepatic Stellate Cells | 1 | 2016 | 10 | 0.040 |
Why?
| | Aspartate Aminotransferases | 1 | 2016 | 95 | 0.040 |
Why?
| | Neutrophils | 1 | 2022 | 1233 | 0.040 |
Why?
| | Connective Tissue | 1 | 2016 | 37 | 0.040 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 1996 | 155 | 0.040 |
Why?
| | Oxidoreductases | 1 | 2016 | 100 | 0.040 |
Why?
| | Tissue Array Analysis | 1 | 2016 | 52 | 0.030 |
Why?
| | Metabolome | 1 | 2019 | 296 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 975 | 0.030 |
Why?
| | Lentivirus | 1 | 2016 | 52 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2018 | 806 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 827 | 0.030 |
Why?
| | Survival Rate | 1 | 2020 | 1720 | 0.030 |
Why?
| | Golgi Apparatus | 1 | 1996 | 91 | 0.030 |
Why?
| | Systems Biology | 1 | 2016 | 57 | 0.030 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 86 | 0.030 |
Why?
| | Glucose Intolerance | 1 | 2016 | 139 | 0.030 |
Why?
| | Deoxyguanosine | 1 | 2015 | 23 | 0.030 |
Why?
| | Calcium-Binding Proteins | 1 | 2016 | 217 | 0.030 |
Why?
| | Chemokine CXCL2 | 1 | 2014 | 44 | 0.030 |
Why?
| | Genotype | 1 | 2020 | 1882 | 0.030 |
Why?
| | Mutation, Missense | 1 | 2017 | 300 | 0.030 |
Why?
| | Catalysis | 1 | 2016 | 295 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 1996 | 510 | 0.030 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 25 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2022 | 1774 | 0.030 |
Why?
| | Tumor Burden | 1 | 2016 | 274 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1085 | 0.030 |
Why?
| | Cytochrome P-450 CYP4A | 1 | 2014 | 6 | 0.030 |
Why?
| | Proto-Oncogene Proteins | 1 | 2018 | 618 | 0.030 |
Why?
| | Kidney Cortex | 1 | 2014 | 31 | 0.030 |
Why?
| | Comet Assay | 1 | 2014 | 15 | 0.030 |
Why?
| | Biopsy | 1 | 2018 | 1079 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2015 | 345 | 0.030 |
Why?
| | Fatty Acid Synthases | 1 | 2014 | 29 | 0.030 |
Why?
| | CD36 Antigens | 1 | 2014 | 42 | 0.030 |
Why?
| | Cell Cycle Proteins | 1 | 2018 | 565 | 0.030 |
Why?
| | Lipopolysaccharide Receptors | 1 | 2014 | 88 | 0.030 |
Why?
| | Exercise Therapy | 1 | 2018 | 355 | 0.030 |
Why?
| | Electrocardiography | 1 | 2017 | 556 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 333 | 0.030 |
Why?
| | Leukocyte Count | 1 | 2014 | 305 | 0.030 |
Why?
| | Cell Line, Transformed | 1 | 2014 | 136 | 0.030 |
Why?
| | Matrix Metalloproteinases | 1 | 2014 | 90 | 0.030 |
Why?
| | Skinfold Thickness | 1 | 2013 | 46 | 0.030 |
Why?
| | Kinetics | 3 | 1987 | 1624 | 0.030 |
Why?
| | Progesterone | 2 | 1987 | 242 | 0.030 |
Why?
| | RNA Interference | 1 | 2016 | 460 | 0.030 |
Why?
| | Homocysteine S-Methyltransferase | 1 | 2013 | 5 | 0.030 |
Why?
| | In Situ Nick-End Labeling | 1 | 2013 | 124 | 0.030 |
Why?
| | Tetraspanin 28 | 2 | 2005 | 4 | 0.030 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2014 | 127 | 0.030 |
Why?
| | Central Nervous System Depressants | 1 | 2014 | 89 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 1996 | 755 | 0.030 |
Why?
| | Binding, Competitive | 3 | 1992 | 205 | 0.030 |
Why?
| | Tongue | 1 | 2013 | 73 | 0.030 |
Why?
| | Stress, Physiological | 1 | 2016 | 415 | 0.030 |
Why?
| | Computational Biology | 1 | 2017 | 588 | 0.030 |
Why?
| | Transcriptome | 1 | 2019 | 756 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2013 | 26 | 0.030 |
Why?
| | Betaine | 1 | 2013 | 64 | 0.030 |
Why?
| | Ketone Bodies | 1 | 2013 | 17 | 0.030 |
Why?
| | Nucleic Acid Conformation | 1 | 1996 | 670 | 0.030 |
Why?
| | Leydig Cells | 1 | 1992 | 12 | 0.030 |
Why?
| | Cell Nucleus | 2 | 2009 | 580 | 0.030 |
Why?
| | Antigens, CD1d | 1 | 2013 | 63 | 0.030 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2015 | 514 | 0.030 |
Why?
| | Theca Cells | 1 | 1992 | 1 | 0.030 |
Why?
| | Dietary Supplements | 1 | 2016 | 467 | 0.030 |
Why?
| | Antibody Specificity | 1 | 1993 | 184 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2019 | 5255 | 0.030 |
Why?
| | Nerve Tissue Proteins | 1 | 2016 | 551 | 0.030 |
Why?
| | Sex Factors | 1 | 2018 | 1781 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1510 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2021 | 4596 | 0.030 |
Why?
| | Actins | 1 | 2014 | 404 | 0.030 |
Why?
| | Species Specificity | 1 | 2013 | 565 | 0.030 |
Why?
| | Antibodies | 1 | 2014 | 392 | 0.030 |
Why?
| | Models, Chemical | 1 | 2014 | 274 | 0.030 |
Why?
| | alpha-Macroglobulins | 1 | 2012 | 24 | 0.030 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2018 | 468 | 0.030 |
Why?
| | Aldehyde Reductase | 1 | 2013 | 101 | 0.030 |
Why?
| | Prognosis | 1 | 2020 | 3443 | 0.030 |
Why?
| | Models, Biological | 2 | 2011 | 1715 | 0.030 |
Why?
| | Caseins | 1 | 2011 | 22 | 0.030 |
Why?
| | Palmitic Acid | 1 | 2011 | 38 | 0.030 |
Why?
| | Amino Acids | 1 | 2015 | 464 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2013 | 490 | 0.030 |
Why?
| | Body Temperature | 1 | 2012 | 215 | 0.030 |
Why?
| | Insulin | 2 | 2016 | 2162 | 0.030 |
Why?
| | Serum Albumin | 1 | 2012 | 146 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2013 | 828 | 0.020 |
Why?
| | Survival Analysis | 1 | 2014 | 1267 | 0.020 |
Why?
| | Lipase | 1 | 2011 | 70 | 0.020 |
Why?
| | Retinal Dehydrogenase | 1 | 2011 | 40 | 0.020 |
Why?
| | Membranes, Artificial | 1 | 2011 | 70 | 0.020 |
Why?
| | Tritium | 1 | 1990 | 70 | 0.020 |
Why?
| | Chromatography, Affinity | 1 | 1990 | 85 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2022 | 1974 | 0.020 |
Why?
| | Cations, Divalent | 1 | 1990 | 52 | 0.020 |
Why?
| | Baculoviridae | 1 | 2010 | 46 | 0.020 |
Why?
| | Blood Pressure | 1 | 2017 | 1664 | 0.020 |
Why?
| | Hypoxia | 1 | 2016 | 963 | 0.020 |
Why?
| | Mitochondria, Liver | 1 | 2010 | 70 | 0.020 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2010 | 140 | 0.020 |
Why?
| | Hydrolysis | 1 | 1990 | 176 | 0.020 |
Why?
| | Insecta | 1 | 2010 | 68 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 146 | 0.020 |
Why?
| | NAD | 1 | 2010 | 67 | 0.020 |
Why?
| | Cell Death | 1 | 2011 | 339 | 0.020 |
Why?
| | Oxidants | 1 | 2010 | 122 | 0.020 |
Why?
| | Cytosol | 1 | 2010 | 221 | 0.020 |
Why?
| | Histones | 1 | 2015 | 552 | 0.020 |
Why?
| | Seasons | 1 | 2012 | 461 | 0.020 |
Why?
| | Urokinase-Type Plasminogen Activator | 1 | 2009 | 30 | 0.020 |
Why?
| | Transgenes | 1 | 2010 | 174 | 0.020 |
Why?
| | Protease Inhibitors | 1 | 1990 | 102 | 0.020 |
Why?
| | HeLa Cells | 2 | 2001 | 583 | 0.020 |
Why?
| | Culture Media, Conditioned | 1 | 2009 | 112 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2011 | 656 | 0.020 |
Why?
| | Plasmids | 1 | 2010 | 355 | 0.020 |
Why?
| | In Vitro Techniques | 2 | 1989 | 1094 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-met | 1 | 2009 | 69 | 0.020 |
Why?
| | Prostaglandins F, Synthetic | 1 | 1989 | 9 | 0.020 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2008 | 55 | 0.020 |
Why?
| | Neutrophil Infiltration | 1 | 2008 | 97 | 0.020 |
Why?
| | Administration, Topical | 1 | 2008 | 141 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2018 | 1515 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2013 | 597 | 0.020 |
Why?
| | Administration, Oral | 1 | 2010 | 756 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2009 | 443 | 0.020 |
Why?
| | Random Allocation | 1 | 2008 | 344 | 0.020 |
Why?
| | Exercise | 1 | 2018 | 1657 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2009 | 544 | 0.020 |
Why?
| | Palmitates | 1 | 2007 | 19 | 0.020 |
Why?
| | Cell Movement | 2 | 2009 | 896 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2007 | 280 | 0.020 |
Why?
| | Reflex, Stretch | 1 | 2006 | 9 | 0.020 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2007 | 57 | 0.020 |
Why?
| | Phosphatidylinositol Diacylglycerol-Lyase | 1 | 1986 | 3 | 0.020 |
Why?
| | Vanadium | 1 | 1986 | 5 | 0.020 |
Why?
| | Carbachol | 1 | 1986 | 20 | 0.020 |
Why?
| | Vanadates | 1 | 1986 | 29 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2018 | 6561 | 0.020 |
Why?
| | Prostaglandins E | 1 | 1986 | 47 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2007 | 336 | 0.020 |
Why?
| | Thymidine | 1 | 1986 | 62 | 0.020 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 1986 | 45 | 0.020 |
Why?
| | Growth Substances | 1 | 1986 | 136 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2007 | 371 | 0.020 |
Why?
| | Infant | 1 | 2019 | 8293 | 0.020 |
Why?
| | Phosphodiesterase Inhibitors | 1 | 1986 | 86 | 0.020 |
Why?
| | Antibodies, Viral | 1 | 2009 | 542 | 0.020 |
Why?
| | PPAR gamma | 1 | 2007 | 188 | 0.020 |
Why?
| | Tetraspanins | 1 | 2005 | 16 | 0.020 |
Why?
| | Epidermal Growth Factor | 1 | 1986 | 173 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2008 | 1293 | 0.020 |
Why?
| | Detergents | 1 | 2005 | 44 | 0.020 |
Why?
| | Dinoprostone | 1 | 1986 | 193 | 0.020 |
Why?
| | Cyclic AMP | 1 | 1986 | 242 | 0.020 |
Why?
| | Peptide Hydrolases | 1 | 1986 | 108 | 0.020 |
Why?
| | Uteroglobin | 2 | 1984 | 16 | 0.020 |
Why?
| | Hydrocortisone | 1 | 1987 | 273 | 0.020 |
Why?
| | Solubility | 1 | 2005 | 235 | 0.020 |
Why?
| | Introns | 1 | 2005 | 234 | 0.020 |
Why?
| | Child, Preschool | 1 | 2018 | 9491 | 0.020 |
Why?
| | Multiprotein Complexes | 1 | 2005 | 149 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2013 | 2275 | 0.010 |
Why?
| | Metformin | 1 | 2007 | 295 | 0.010 |
Why?
| | Testosterone | 1 | 1987 | 351 | 0.010 |
Why?
| | Glucagon | 1 | 2003 | 97 | 0.010 |
Why?
| | Aging | 1 | 1992 | 1670 | 0.010 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2005 | 211 | 0.010 |
Why?
| | Tumor Virus Infections | 1 | 2002 | 41 | 0.010 |
Why?
| | Fibroblasts | 1 | 2007 | 842 | 0.010 |
Why?
| | Spectrometry, Fluorescence | 2 | 1979 | 173 | 0.010 |
Why?
| | Uterine Cervical Dysplasia | 1 | 2002 | 38 | 0.010 |
Why?
| | Papillomaviridae | 1 | 2002 | 101 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2002 | 311 | 0.010 |
Why?
| | Mucous Membrane | 1 | 2002 | 113 | 0.010 |
Why?
| | Photochemistry | 2 | 1992 | 136 | 0.010 |
Why?
| | Sheep | 3 | 1992 | 764 | 0.010 |
Why?
| | Membrane Microdomains | 1 | 2000 | 35 | 0.010 |
Why?
| | Fluorescent Dyes | 2 | 1979 | 316 | 0.010 |
Why?
| | Gestational Age | 1 | 2003 | 765 | 0.010 |
Why?
| | Polyribosomes | 1 | 1980 | 23 | 0.010 |
Why?
| | Molecular Structure | 2 | 1992 | 459 | 0.010 |
Why?
| | Macromolecular Substances | 1 | 2000 | 201 | 0.010 |
Why?
| | Keratins | 1 | 2001 | 174 | 0.010 |
Why?
| | Hyperplasia | 1 | 2001 | 170 | 0.010 |
Why?
| | Thyrotropin | 1 | 1980 | 105 | 0.010 |
Why?
| | DNA, Viral | 1 | 2002 | 356 | 0.010 |
Why?
| | Thyroid Gland | 1 | 1980 | 84 | 0.010 |
Why?
| | Cytological Techniques | 1 | 1979 | 24 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 18480 | 0.010 |
Why?
| | Hypoglycemic Agents | 1 | 2007 | 1032 | 0.010 |
Why?
| | Fetus | 1 | 2003 | 690 | 0.010 |
Why?
| | Chromomycins | 1 | 1978 | 1 | 0.010 |
Why?
| | Olivomycins | 1 | 1978 | 1 | 0.010 |
Why?
| | Plicamycin | 1 | 1978 | 3 | 0.010 |
Why?
| | Child | 1 | 2018 | 19129 | 0.010 |
Why?
| | Papillomavirus Infections | 1 | 2002 | 265 | 0.010 |
Why?
| | Peptides, Cyclic | 1 | 1978 | 260 | 0.010 |
Why?
| | Cell Cycle | 1 | 1978 | 550 | 0.010 |
Why?
| | Polyethylene Glycols | 1 | 2000 | 578 | 0.010 |
Why?
| | RNA | 1 | 1980 | 833 | 0.010 |
Why?
| | Luteal Cells | 1 | 1992 | 2 | 0.010 |
Why?
| | Esters | 1 | 1992 | 61 | 0.010 |
Why?
| | Chemistry | 1 | 1989 | 39 | 0.010 |
Why?
| | Chemical Phenomena | 1 | 1989 | 82 | 0.010 |
Why?
| | Estrogen Antagonists | 1 | 1984 | 39 | 0.000 |
Why?
| | Poly A | 1 | 1980 | 47 | 0.000 |
Why?
| | RNA, Ribosomal | 1 | 1980 | 158 | 0.000 |
Why?
| | Fixatives | 1 | 1978 | 16 | 0.000 |
Why?
| | Leukemia, Experimental | 1 | 1978 | 27 | 0.000 |
Why?
| | Cricetinae | 1 | 1978 | 262 | 0.000 |
Why?
| | Osmolar Concentration | 1 | 1978 | 185 | 0.000 |
Why?
| | Magnesium | 1 | 1978 | 150 | 0.000 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1978 | 536 | 0.000 |
Why?
|
|
Orlicky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|